Detail Information of Genetic Polymorphisms
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0084 Transporter Info | ||||
Gene Name | SLC12A3 | ||||
Protein Name | Thiazide-sensitive sodium-chloride cotransporter | ||||
Gene ID | |||||
UniProt ID | |||||
Genetic Polymorphisms of DT (GPD) | |||||
Genetic Polymorphism | rs13306673 | ||||
Site of GPD | chr16:56867019 (GRCh38.p12) | ||||
GPD Type | SNP | ||||
Allele(s) in dbSNP | C>T | ||||
Minor Allele Frequency | T=0.1488/745 (Global) | ||||
Genotype CC | Click to Show/Hide the Full List of Affected Drugs: 1 Drugs in Total | ||||
Thiazides | N.A. | Essential Hypertension | Correlated with the increased reduction in mean blood pressure in patients (compare with Genotypes CT + TT) | [ 1] | |
Genetic Polymorphism | rs1529927 | ||||
Site of GPD | chr16:56870675 (GRCh38.p12) | ||||
GPD Type | SNP | ||||
Allele(s) in dbSNP | C>G | ||||
Minor Allele Frequency | C=0.0094/47 (Global) | ||||
Allele C | Click to Show/Hide the Full List of Affected Drugs: 3 Drugs in Total | ||||
Torsemide | Drug Info | Healthy Individuals | Correlated with the increased 24-h excretion of chloride and potassium in healthy individuals (compare with Allele G) | [ 2] | |
Furosemide | Drug Info | Healthy Individuals | Correlated with the increased 24-h excretion of chloride and potassium in healthy individuals (compare with Allele G) | [ 2] | |
Bumetanide | Drug Info | Healthy Individuals | Correlated with the increased 24-h excretion of chloride and potassium in healthy individuals (compare with Allele G) | [ 2] | |
Genotype CC | Click to Show/Hide the Full List of Affected Drugs: 3 Drugs in Total | ||||
Torsemide | Drug Info | Healthy Individuals | Correlated with the increased drug response in healthy individuals (compare with genotype GG) | [ 3] | |
Furosemide | Drug Info | Healthy Individuals | Correlated with the increased drug response in healthy individuals (compare with genotype GG) | [ 3] | |
Bumetanide | Drug Info | Healthy Individuals | Correlated with the increased drug response in healthy individuals (compare with genotype GG) | [ 3] | |
References | |||||
1 | The thiazide-sensitive Na(+)-Cl(-) cotransporter gene, C1784T, and adrenergic receptor-beta3 gene, T727C, may be gene polymorphisms susceptible to the antihypertensive effect of thiazide diuretics. Hypertens Res. 2004 Nov;27(11):821-33. | ||||
2 | Genetic variation in the renal sodium transporters NKCC2, NCC, and ENaC in relation to the effects of loop diuretic drugs. Clin Pharmacol Ther. 2007 Sep;82(3):300-9. | ||||
3 | The genetics of loop diuretic effects. Pharmacogenomics J. 2012 Feb;12(1):45-53. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.